Taya Glotzer MD in Englewood, New Jersey

Additional Medical Specialties Include:
CARDIAC ELECTROPHYSIOLOGY

Medical School: New York University School Of Medicine
Graduation Year: 1987
The Primary Medical Specialty for Taya Glotzer MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 37
PAC (PECOS ID)#: 2961474622
NPI #: 1376510792
NPI Created On: 03/03/2006
NPI Last Updated Listed as: 07/10/2008
Primary Taxonomy Code: 207RC0001X
License Number:
25MA06231100
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• AmeriHealth New Jersey
• Humana
• Oscar Garden State Insurance Corporation
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Insertion of new or replacement of permanent pacemaker including upper and lower chamber electrodes
2. External shock to heart to regulate heart beat
3. Routine ekg using at least 12 leads including interpretation and report
4. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
5. Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report
6. Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report
7. Evaluation, testing and programming adjustment of defibrillator with analysis, review and report
8. Evaluation, testing and programming adjustment of defibrillator with analysis, review and report
9. Evaluation, testing and programming adjustment of defibrillator with analysis, review and report
10. Evaluation of parameters of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report
11. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
12. Remote evaluations of defibrillator up to 90 days with analysis, review and report
13. Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
14. Remote evaluations of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report, up to 30 days
15. New patient office or other outpatient visit, typically 45 minutes
16. Established patient office or other outpatient, visit typically 25 minutes
17. Initial hospital inpatient care, typically 70 minutes per day
18. Subsequent hospital inpatient care, typically 25 minutes per day
19. Subsequent hospital inpatient care, typically 35 minutes per day
20. Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec